✦ LIBER ✦

A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up

✍ Scribed by Julka, Pramod K.; Chacko, Raju T.; Nag, Shona; Parshad, Rajinder; Nair, Aravindan; Koppiker, Chaitanyanand B.; Xue, Fen Chao Richard; Barraclough, Helen; Dhindsa, Navreet; Seth, Anil; Majumdar, Anurita; Puri, Tarun

Book ID: 118174281
Publisher: Springer Japan
Year: 2012
Tongue: English
Weight: 244 KB
Volume: 20
Category: Article
ISSN: 1340-6868
DOI: 10.1007/s12282-012-0343-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 2 clinical trial of sequential n

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer : Final results

✍ Arlene O. Siefker-Radtke; Colin P. Dinney; Yu Shen; Dallas L. Williams; Ashish M 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Biweekly docetaxel and gemcitabine as ne

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study

✍ L. G. Estévez; P. Sánchez-Rovira; M. Dómine; A. León; I. Calvo; A. Jaén; V. Casa 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 80 KB

A multicenter phase II study of sequenti

A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer

✍ Pallis, Athanasios G.; Agelidou, Athina; Papakotoulas, Pavlos; Tsaroucha, Aimili 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 150 KB

A phase III randomized trial comparing v

A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors

✍ Kodani, Tsuyoshi; Ueoka, Hiroshi; Kiura, Katsuyuki; Tabata, Masahiro; Takigawa, 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

Late-Breaking Abstract 5: Results from a

Late-Breaking Abstract 5: Results from a 2nd interim OS analysis in OCEANS: A randomized phase 3 trial of gemcitabine (G), carboplatin (C) and bevacizumab (BV) followed by BV to disease progression in patients with platinum-sensitive recurrent epithelial ovarian (OC), primary peritoneal (PPC), or fallopian tube cancer (FTC)

✍ C. Aghajanian; S. Blank; B. Goff; P. Judson; L. Nycum; M. Sovak; J. Yi; A. Husai 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 42 KB